Cargando…
PCSK9: A Potential Therapeutic Target for Sepsis
Sepsis is a life-threatening organ dysfunction syndrome caused by a dysregulated host response to infection. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is often upregulated in the presence of sepsis and infectious diseases. In sepsis, PCSK9 degraded the low-density lipoprotein cholesterol...
Autores principales: | Yuan, Yuan, Wu, Wei, Sun, Shanshan, Zhang, Yi, Chen, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584934/ https://www.ncbi.nlm.nih.gov/pubmed/33123601 http://dx.doi.org/10.1155/2020/2687692 |
Ejemplares similares
-
PCSK9 as a therapeutic target for cardiovascular disease
por: Zhang, Pei-Ying
Publicado: (2017) -
A Genetic Approach to the Association Between PCSK9 and Sepsis
por: Feng, QiPing, et al.
Publicado: (2019) -
A Therapeutic Peptide Vaccine Against PCSK9
por: Pan, Yajie, et al.
Publicado: (2017) -
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
por: Lee, Ji Soo, et al.
Publicado: (2019) -
The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)